Biodesix Inc (BDSX): Cash & Equivalents
$18.99M
As of 2025-12-31
$30.00M
As of 2026-06-30
-23.9%
3-year compound annual growth
-21.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.99M | -27.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $26.25M | -0.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $26.28M | -39.0% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $43.09M | +31.7% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $32.71M | -47.3% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $62.13M | n/m | 2022-03-14, Balance as of period end |
| 2019-12-31 | $5.29M | n/a | 2021-03-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Biodesix Inc (BDSX) | 2025-12-31 | $18.99M | -27.7% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $124.25M | +35.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $32.22M | +46.2% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $249.73M | +16.6% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $3.46M | -68.6% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗